Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for inpatient major bleeding during the first 6 months after treatment initiation comparing Dabigatran and Rivaroxaban vs Apixaban among non-valvular atrial fibrillation (NVAF) patients.</p
International audienceBACKGROUND:Among atrial fibrillation patients undergoing percutaneous coronary...
Dabigatran and rivaroxaban at standard (SD) or reduced doses (RD) have been compared to warfarin in ...
Objective: To compare effectiveness and safety of warfarin and the direct oral anticoagulants (DOAC)...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for any, major, and clinically relev...
Sensitivity analysis using only patients initiated with standard dosage adjusted hazard ratios (HRs)...
Sensitivity analysis—Inverse probability treatment weighting IPTW analyses: Adjusted hazard ratios (...
Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist o...
Introduction Patients treated with direct oral anticoagulants (DOACs) are at increased bleeding risk...
Unadjusted annual cumulative incidence of bleeding among non-valvular atrial fibrillation (nvaf) pat...
The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding...
Different outcomes among patients hospitalized for bleeding after starting anticoagulation could inf...
The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding...
Shown are the odds ratio (OR) and 95% confidence interval (CI) for each variable. For variables with...
Aims: To compare the risk of all-cause hospitalization and hospitalizations due to stroke/systemic e...
The ARISTOTLE trial showed a risk reduction of stroke/systemic embolism (SE) and major bleeding in n...
International audienceBACKGROUND:Among atrial fibrillation patients undergoing percutaneous coronary...
Dabigatran and rivaroxaban at standard (SD) or reduced doses (RD) have been compared to warfarin in ...
Objective: To compare effectiveness and safety of warfarin and the direct oral anticoagulants (DOAC)...
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for any, major, and clinically relev...
Sensitivity analysis using only patients initiated with standard dosage adjusted hazard ratios (HRs)...
Sensitivity analysis—Inverse probability treatment weighting IPTW analyses: Adjusted hazard ratios (...
Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist o...
Introduction Patients treated with direct oral anticoagulants (DOACs) are at increased bleeding risk...
Unadjusted annual cumulative incidence of bleeding among non-valvular atrial fibrillation (nvaf) pat...
The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding...
Different outcomes among patients hospitalized for bleeding after starting anticoagulation could inf...
The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding...
Shown are the odds ratio (OR) and 95% confidence interval (CI) for each variable. For variables with...
Aims: To compare the risk of all-cause hospitalization and hospitalizations due to stroke/systemic e...
The ARISTOTLE trial showed a risk reduction of stroke/systemic embolism (SE) and major bleeding in n...
International audienceBACKGROUND:Among atrial fibrillation patients undergoing percutaneous coronary...
Dabigatran and rivaroxaban at standard (SD) or reduced doses (RD) have been compared to warfarin in ...
Objective: To compare effectiveness and safety of warfarin and the direct oral anticoagulants (DOAC)...